SK
Sudha Kumari
About Sudha Kumari
Data last updated:
Sudha Kumari is a Director at Harrill Pharmaceutical Private Limited (since 2023) and Director at Phyllan Pharmaceutical Private Limited (since 2018). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jan 2023 | 2023 | Active | ||
| Director | 29 Nov 2018 | 2018 | Active |
Board colleagues of Sudha Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Munna Ram | 08054743 | Harrill Pharmaceutical Private Limited , Phyllan Pharmaceutical Private Limited | Director |
| Tanya Kaushik | 08920865 | Phyllan Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudha Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudha Kumari
Sudha Kumari currently holds 2 directorships: Harrill Pharmaceutical Private Limited (Director, since 05 Jan 2023); Phyllan Pharmaceutical Private Limited (Director, since 29 Nov 2018).
Sudha Kumari was first appointed on 29 Nov 2018 as Director at Phyllan Pharmaceutical Private Limited. The most recent appointment on record is 05 Jan 2023 at Harrill Pharmaceutical Private Limited.
The current boards of Sudha Kumari's companies include Munna Ram (Harrill Pharmaceutical Private Limited), Tanya Kaushik (Phyllan Pharmaceutical Private Limited).